Assyro AI

Orange Book product · Brand (NDA)

INZIRQO

HYDROCHLOROTHIAZIDE

Brand (NDA)NDA 219141RX NOVITIUM PHARMA

At a glance

Jan 28, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 28, 2025

    1 yr 5 mo ago

  2. Today

  3. Patent 11878022 expires

    Listed drug product patent expiration.

    Jan 23, 2044

    in 17 yr 10 mo

  4. Patent 11878022 expires

    Listed drug product patent expiration.

    Jan 23, 2044

    in 17 yr 10 mo

Pharmaceutical detail

Active ingredient

HYDROCHLOROTHIAZIDE

Strength

10MG/ML

Dosage form

FOR SUSPENSION

Route

ORAL

TE code

Not listed

Application

NDA 219141

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11878022Jan 23, 2044in 17 yr 10 mo
ProductU-4138
11878022Jan 23, 2044in 17 yr 10 mo
ProductU-4139
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.